COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,886 Articles (22,568 medRxiv, 8,318 bioRxiv)

Most recent first Previous |  Page 1695: Articles 16941-16950  | Next

Systemic Tissue and Cellular Disruption from SARS-CoV-2 Infection revealed in COVID-19 Autopsies and Spatial Omics Tissue Maps
Park, J., Foox, J., Hether, T., Danko, D., Warren, S., Kim, Y., Reeves, J., Butler, D. J., Mozsary, C., Rosiene, J., Shaiber, A., Afshinnekoo, E., MacKay, M., Bram, Y., Chandar, V., Geiger, H., Craney, A., Velu, P., Melnick, A. M., Hajirasouliha, I., Beheshti, A., Taylor, D., Saravia-Butler, A., Singh, U., Wurtele, E. S., Schisler, J., Fenessey, S., Corvelo, A., Zody, M. C., Germer, S., Salvatore, S., Levy, S., Wu, S., Tatonetti, N., Shapira, S., Salvatore, M., Loda, M., Westblade, L. F., Cushing, M., Rennert, H., Kriegel, A. J., Elemento, O., Imielinski, M., Borczuk, A. C., Meydan, C., Schwartz, R. E., Mason, C. E.
10.1101/2021.03.08.434433 — Posted: 2021-03-09
The N501Y spike substitution enhances SARS-CoV-2 transmission
Liu, Y., Liu, J., Plante, K. S., Plante, J. A., Xie, X., Zhang, X., Ku, Z., An, Z., Scharton, D., Schindewolf, C., Menachery, V. D., Shi, P.-Y., Weaver, S. C.
10.1101/2021.03.08.434499 — Posted: 2021-03-09
Spike mutations in SARS-CoV-2 variants confer resistance to antibody neutralization
Wang, R., Zhang, Q., Ge, J., Ren, W., Zhang, R., Lan, J., Ju, B., Su, B., Yu, F., Chen, P., Liao, H., Feng, Y., Li, X., Shi, X., Zhang, Z., Zhang, F., Ding, Q., Zhang, T., Wang, X., Zhang, L.
10.1101/2021.03.09.434497 — Posted: 2021-03-09
Beliefs about Mask Efficacy and the Effect of Social Norms on Mask Wearing Intentions for COVID-19 Risk Reduction
Bokemper, S. E., Cucciniello, M., Rotesi, T. E., Pin, P., Malik, A. A., Willebrand, K., Paintsil, E. E., Omer, S. B., Huber, G. A., Melegaro, A.
10.1101/2021.03.02.21252722 — Posted: 2021-03-09
Vaccine effectiveness after 1st and 2nd dose of the BNT162b2 mRNA Covid-19 Vaccine in long-term care facility residents and healthcare workers - a Danish cohort study
Moustsen-Helms, I. R., Emborg, H.-D., Nielsen, J., Nielsen, K. F., Krause, T. G., Molbak, K., Moeller, K. L., Berthelsen, A.-S. N., Valentiner-Branth, P.
10.1101/2021.03.08.21252200 — Posted: 2021-03-09 Discussion: Onsite
Transmission of SARS-CoV-2 by children attending school. Interim report on an observational, longitudinal sampling study of infected children, contacts, and the environment
Cordery, R., Reeves, L., Zhou, J., Rowan, A. G., Watber, P., Rosadas, C., Crone, M. A., Freemont, P., Mosscrop, L., Cowley, A., Zelent, G., Bisset, K., LeBlond, H., Regmi, S., Mindlin, M., Lamagni, T., Barclay, W., Taylor, G. P., Sriskandan, S.
10.1101/2021.03.08.21252839 — Posted: 2021-03-09
Single-Arm, Open-Label Phase 2 Trial of Preemptive Methylprednisolone to Avert Progression to Respiratory Failure in High-Risk Patients with COVID-19
Cabanillas, F., Morales, J., Conde, J. G., Bertran-Pasarell, J., Fernandez, R., Hernandez-Silva, Y., Liboy, I., Bryan-Diaz, J., Arraut-Gonzalez, J.
10.1101/2021.03.08.21253117 — Posted: 2021-03-09
SARS-COV-2 antibody prevalence in patients on dialysis in the US in January 2021
Anand, S., Montez-Rath, M., Han, J., Cadden, L., Hunsader, P., Kerschmann, R., Beyer, P., Boyd, S. D., Garcia, P., Dittrich, M., Block, G. A., Parsonnet, J., Chertow, G. M.
10.1101/2021.03.07.21252786 — Posted: 2021-03-09
The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies that target both the NTD and the RBD
Amanat, F., Thapa, M., Lei, T., Ahmed, S. M. S., Adelsberg, D. C., Carreno, J. M., Strohmeier, S., Schmitz, A. J., Zafar, S., Zhou, J. Q., Rijnink, W., Alshammary, H., Borcherding, N., Gonzalez Reiche, A., Srivastava, K., Sordillo, E. M., van Bakel, H., Turner, J. S., Bajic, G., Simon, V. M., Ellebedy, A. H., Krammer, F.
10.1101/2021.03.07.21253098 — Posted: 2021-03-09 Discussion: Onsite
A general computational framework for COVID-19 modelling, with applications to testing varied interventions in education environments
Moore, J. W., Lau, Z., Kaouri, K., Dale, T. C., Woolley, T. E.
10.1101/2021.03.08.21253122 — Posted: 2021-03-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).